News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
105,947 Results
Type
Article (6202)
Company Profile (12)
Press Release (99733)
Section
Business (36275)
Career Advice (321)
Deals (4666)
Drug Delivery (8)
Drug Development (14645)
Employer Resources (14)
FDA (2539)
Job Trends (2344)
News (57769)
Policy (3942)
Tag
2024 Biotech Bay Standard (3)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (2)
2024 Genetown Standard (1)
2024 Pharm Country Digital (1)
Academia (607)
Adcomms (3)
Allergies (15)
Alliances (8985)
ALS (22)
Alzheimer's disease (303)
Antibody-drug conjugate (ADC) (19)
Approvals (2570)
Artificial intelligence (46)
Autoimmune disease (3)
Automation (1)
Bankruptcy (48)
Best Places to Work (2123)
BIOSECURE Act (3)
Biosimilars (14)
Biotechnology (8)
Bladder cancer (9)
Brain cancer (4)
Breast cancer (34)
Cancer (353)
Cardiovascular disease (32)
Career advice (227)
Career pathing (1)
CAR-T (21)
Cell therapy (55)
Cervical cancer (2)
Clinical research (12485)
Collaboration (168)
Compensation (16)
Complete response letters (2)
COVID-19 (293)
CRISPR (9)
C-suite (89)
Cystic fibrosis (26)
Data (431)
Depression (4)
Diabetes (21)
Diagnostics (975)
Digital health (3)
Diversity, equity & inclusion (5)
Drug discovery (24)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (19)
Earnings (8701)
Editorial (1)
Employer branding (1)
Employer resources (13)
Events (10722)
Executive appointments (296)
FDA (2741)
Featured Employer (3)
Frontotemporal dementia (2)
Funding (120)
Gene editing (15)
Generative AI (5)
Gene therapy (35)
GLP-1 (104)
Government (418)
Grass and pollen (1)
Guidances (6)
Healthcare (2923)
Huntington's disease (2)
IgA nephropathy (4)
Immunology and inflammation (29)
Indications (8)
Infectious disease (307)
Inflammatory bowel disease (66)
Inflation Reduction Act (1)
Influenza (5)
Intellectual property (15)
Interviews (31)
IPO (1904)
IRA (6)
Job creations (335)
Job search strategy (208)
Kidney cancer (3)
Labor market (1)
Layoffs (35)
Legal (618)
Liver cancer (14)
Lung cancer (71)
Lymphoma (24)
Machine learning (1)
Management (4)
Manufacturing (35)
MASH (20)
Medical device (1897)
Medtech (1898)
Mergers & acquisitions (2828)
Metabolic disorders (77)
Multiple sclerosis (20)
NASH (7)
Neurodegenerative disease (22)
Neuropsychiatric disorders (4)
Neuroscience (413)
NextGen: Class of 2025 (1103)
Non-profit (637)
Northern California (462)
Obesity (35)
Opinion (24)
Ovarian cancer (18)
Pain (11)
Pancreatic cancer (9)
Parkinson's disease (25)
Partnered (1)
Patents (32)
Patient recruitment (16)
Peanut (9)
People (17254)
Pharmaceutical (5)
Phase I (3230)
Phase II (5264)
Phase III (5035)
Pipeline (188)
Podcasts (2)
Policy (13)
Postmarket research (443)
Preclinical (1086)
Press Release (12)
Prostate cancer (15)
Psychedelics (5)
Radiopharmaceuticals (54)
Rare diseases (86)
Real estate (804)
Recruiting (5)
Regulatory (3268)
Reports (9)
Research institute (497)
Resumes & cover letters (100)
Rett syndrome (1)
RNA editing (2)
RSV (3)
Schizophrenia (17)
Series A (17)
Series B (18)
Sickle cell disease (11)
Southern California (487)
Sponsored (5)
Startups (672)
State (1)
Stomach cancer (1)
Supply chain (9)
The Weekly (2)
United States (3515)
Vaccines (74)
Venture capitalists (7)
Webinars (3)
Weight loss (17)
Women's health (2)
Date
Today (18)
Last 7 days (133)
Last 30 days (597)
Last 365 days (6486)
2025 (1250)
2024 (6578)
2023 (7127)
2022 (9932)
2021 (9886)
2020 (8966)
2019 (8343)
2018 (6184)
2017 (5619)
2016 (4890)
2015 (5501)
2014 (3951)
2013 (3431)
2012 (3619)
2011 (3827)
2010 (3232)
Location
Africa (107)
Alabama (11)
Alaska (2)
Arizona (37)
Arkansas (5)
Asia (6208)
Australia (987)
California (1123)
Canada (301)
China (85)
Colorado (44)
Connecticut (46)
Delaware (32)
Europe (16645)
Florida (133)
Georgia (36)
Idaho (10)
Illinois (54)
India (4)
Indiana (50)
Japan (53)
Kansas (18)
Kentucky (2)
Louisiana (4)
Maine (3)
Maryland (77)
Massachusetts (589)
Michigan (20)
Minnesota (39)
Missouri (13)
Montana (1)
Nebraska (4)
Nevada (11)
New Hampshire (4)
New Jersey (313)
New Mexico (4)
New York (281)
North Carolina (132)
North Dakota (4)
Northern California (462)
Ohio (48)
Oklahoma (3)
Oregon (5)
Pennsylvania (197)
Rhode Island (1)
South America (110)
Southern California (487)
Tennessee (17)
Texas (116)
Utah (34)
Virginia (20)
Washington D.C. (5)
Washington State (75)
West Virginia (1)
Wisconsin (9)
105,947 Results for "uc berkeley extension".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
UC Berkeley Launches New Molecular Therapeutics Initiative to Accelerate Drug Discovery
The University of California, Berkeley Molecular Therapeutics (MTx) division of the Molecular & Cell Biology department today announced the launch of a new initiative to accelerate drug discovery at the interface of academia and biotech.
March 14, 2024
·
5 min read
BioMidwest
DNA Nanobots Gains Exclusive License to UC Berkeley Gene Editing Technology Platform for Non-Viral Gene Delivery Solution using DNA Nanoparticles and CRISPR-Cas
DNA Nanobots, a biotechnology leader in DNA nanoparticles engineered for targeted therapeutics, announced that it completed exclusive commercial licensing of a gene editing technology from the University of California Berkeley.
June 5, 2024
·
2 min read
Biotech Bay
CatenaBio Selected to Present on its Next Generation Platform and Multi Payload Conjugates (MPC®) at the Berkeley Bio Startup Showcase @JPM
CatenaBio today announced that it has been selected by the Innovative Genomics Institute, a joint effort between UC Berkeley and UC San Francisco, to present on its proprietary CysTyr® Conjugation platform at the Berkeley Bio Startup Showcase during the J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 9, 2024.
January 4, 2024
·
4 min read
Berkeley SkyDeck Joins UC Berkeley’s Life Sciences Entrepreneurship Center to Help Launch Berkeley Faculty-Led Startups
Berkeley SkyDeck, the global hub for entrepreneurship and a leading accelerator, today announced that it has welcomed the first three companies for its new SkyDeck LSEC Bio Track: AsparaGlue, Editpep, and MZR Neurotech
May 2, 2023
·
4 min read
Press Releases
Palisade Bio, Inc. Announces Receipt of Cash Proceeds from Canada’s SR&ED Tax Incentive Program for Reimbursement of Development Costs of PALI-2108 for Treatment of Ulcerative Colitis (UC)
February 20, 2025
·
4 min read
Business
BridgeBio Pharma Announces Founding Affiliation with Bakar Labs, Incubator at UC Berkeley’s Bakar BioEnginuity Hub
BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced its founding affiliation with Bakar Labs, the incubator at UC Berkeley’s Bakar BioEnginuity Hub.
July 21, 2022
·
5 min read
Biotech Beach
Immunis Welcomes UC Berkeley Professor Irina Conboy to the Scientific Advisory Board
Immunis, Inc., a private biotech company creating novel cellular secretome therapies for age and disease-related immune decline, is delighted to have Professor Irina Conboy on its Scientific Advisory Board.
September 28, 2023
·
3 min read
Press Releases
Palisade Bio to Present Preclinical Results for PALI-2108 Demonstrating Engagement of Key Fibrotic Pathways of Crohn’s Disease and Ulcerative Colitis (UC)
November 21, 2024
·
6 min read
Press Releases
Palisade Bio Announces First Subject Dosed in Phase 1 Clinical Study of PALI-2108 for the Treatment of Moderate-to-Severe Ulcerative Colitis (UC)
November 7, 2024
·
5 min read
Press Releases
Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA
October 23, 2024
·
6 min read
1 of 10,595
Next
